POZZAN, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 211
AS - Asia 138
SA - Sud America 2
AF - Africa 1
Totale 595
Nazione #
US - Stati Uniti d'America 242
IT - Italia 80
HK - Hong Kong 69
CN - Cina 39
SE - Svezia 39
DE - Germania 19
IE - Irlanda 14
FI - Finlandia 13
CH - Svizzera 12
KR - Corea 12
SG - Singapore 11
BG - Bulgaria 6
IN - India 6
BE - Belgio 5
ES - Italia 4
RO - Romania 4
AT - Austria 3
FR - Francia 3
GB - Regno Unito 2
NL - Olanda 2
PT - Portogallo 2
BR - Brasile 1
BY - Bielorussia 1
CA - Canada 1
CL - Cile 1
RU - Federazione Russa 1
SN - Senegal 1
TR - Turchia 1
UA - Ucraina 1
Totale 595
Città #
Hong Kong 68
Chandler 64
Ashburn 34
Redmond 17
Trieste 16
Beijing 14
Dublin 14
Bern 12
Princeton 12
Seoul 12
Boardman 8
Helsinki 8
Cividale del Friuli 7
Milan 7
Sofia 6
Ann Arbor 5
Bremen 5
Brussels 5
Columbus 5
Lappeenranta 5
Udine 5
Calcinato 4
Pune 4
Timișoara 4
Washington 4
Mantova 3
Rome 3
Seattle 3
Vienna 3
Ciudad Real 2
Coimbra 2
Council Bluffs 2
Grafing 2
Madrid 2
Paris 2
Parma 2
Potenza 2
Shanghai 2
Tirunelveli 2
Wilmington 2
Woodbridge 2
Amsterdam 1
Ankara 1
Berlin 1
Brescia 1
Capriva del Friuli 1
Cesena 1
Cormons 1
Correggio 1
Dakar 1
Fagagna 1
Fairfield 1
Kerken 1
Krefeld 1
London 1
Minsk 1
Montréal 1
New York 1
Padova 1
Pasian di Prato 1
Roveredo in Piano 1
San Severo 1
Santa Clara 1
Suffern 1
Tavagnacco 1
Tolmezzo 1
Trento 1
Tuttlingen 1
Valenciennes 1
Totale 409
Nome #
Chronic Thromboembolic Pulmonary Hypertension: An Update 69
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 64
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 51
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 49
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 47
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 47
Editorial: Evolution in respiratory pharmacology 46
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 45
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 44
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 42
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 37
Host-Based Treatments for Severe COVID-19 29
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 20
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 19
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 19
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 17
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 13
Totale 658
Categoria #
all - tutte 2.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202288 0 0 0 6 2 4 19 4 21 1 1 30
2022/2023257 21 29 33 21 17 25 7 25 37 5 26 11
2023/2024313 24 16 18 23 35 59 90 32 15 1 0 0
Totale 658